Cytokine-Independent Detection of Antigen-Specific Germinal Center T Follicular Helper Cells in Immunized Nonhuman Primates Using a Live Cell Activation-Induced Marker Technique-Reference-Cited by-同舟云学术

Cytokine-Independent Detection of Antigen-Specific Germinal Center T Follicular Helper Cells in Immunized Nonhuman Primates Using a Live Cell Activation-Induced Marker Technique

Published:2016-06-22 Issue:3 Volume:197 Page:994-1002
ISSN:0022-1767
Container-title:The Journal of Immunology
language:en
Short-container-title:J.I.

Author:

Havenar-Daughton Colin,Reiss Samantha M.^ORCID,Carnathan Diane G.,Wu Jennifer E.,Kendric Kayla^ORCID,Torrents de la Peña Alba,Kasturi Sudhir Pai^ORCID,Dan Jennifer M.^ORCID,Bothwell Marcella^ORCID,Sanders Rogier W.,Pulendran Bali,Silvestri Guido,Crotty Shane^ORCID

Publisher

The American Association of Immunologists

Subject

Immunology,Immunology and Allergy

Reference48 articles.

1. Vaccines: Correlates of Vaccine‐Induced Immunity

2. HIV-1 neutralizing antibodies induced by native-like envelope trimers

3. Haynes B. F. Moody M. A. Alam M. Bonsignori M. Verkoczy L. Ferrari G. Gao F. Tomaras G. D. Liao H.-X. Kelsoe G. . 2014. Progress in HIV-1 vaccine development. J. Allergy Clin. Immunol. 134: 3–10– quiz 11.

4. Antibody responses to envelope glycoproteins in HIV-1 infection

5. Germinal Centers

Cited by 122 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. SARS-CoV-2 inflammation durably imprints memory CD4 T cells;Science Immunology;2024-06-21

2. The self-reactive FVIII T cell repertoire in healthy individuals relies on a short set of epitopes and public clonotypes;Frontiers in Immunology;2024-03-06

3. Enhanced detection of antigen-specific T cells by a multiplexed AIM assay;Cell Reports Methods;2024-01

4. Vaccine induction of CD4-mimicking HIV-1 broadly neutralizing antibody precursors in macaques;Cell;2024-01

5. Safety and Immunogenicity of an Inactivated Recombinant Newcastle Disease Virus Vaccine Expressing Sars-Cov-2 Spike: A Randomised, Comparator-Controlled, Phase 2 Trial;2024